Bradykinin attenuates glucagon-induced leucine oxidation in humans

W. H. Hartl, H. Miyoshi, F. Jahoor, S. Klein, D. Elahi, R. R. Wolfe

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Trauma and injury are associated with accelerated protein loss. Counterregulatory hormones are possible mediatos of this response. In the present study, the effect of glucagon and glucagon plus bradykinin on leucine and urea kinetics was examined in nine normal volunteers during somatostatin infusion and basal insulin replacement. Bradykinin was given because of its prostaglandin-stimulating qualities and the potential anabolic action of prostaglandins. Physiological hyperglucagonemia elicited a small but significant reduction of total leucine flux and rate of urea synthesis. Simultaneously, leucine oxidation increased by 70%. The simultaneous infusion of bradykinin did not alter glucagon-related changes in urea or leucine kinetics. Bradykinin, however, significantly attenuated the stimulation of leucine oxidation by glucagon. These results suggest that glucagon and tissue factors are involved in controlling leucine metabolism in humans.

Original languageEnglish
Pages (from-to)E239-E245
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume259
Issue number2 22-2
StatePublished - Jan 1 1990
Externally publishedYes

Keywords

  • Bradykinin
  • Glucagon
  • Leucine production
  • Urea production

Fingerprint Dive into the research topics of 'Bradykinin attenuates glucagon-induced leucine oxidation in humans'. Together they form a unique fingerprint.

  • Cite this

    Hartl, W. H., Miyoshi, H., Jahoor, F., Klein, S., Elahi, D., & Wolfe, R. R. (1990). Bradykinin attenuates glucagon-induced leucine oxidation in humans. American Journal of Physiology - Endocrinology and Metabolism, 259(2 22-2), E239-E245.